|
| 20200117 Procalcitonin to Distinguish Viral From Bacterial Pneumonia |  |
| 20200207 1st line EGFR mutant NSCLC | |
| 20200221 Pulmonary illness related to E-Cigarette use in Illinois and Wisconsin preliminary | |
| 20200619 Journal Reading on COVID-19 | |
| 20200710 外師：Treatment of Community-acquired pneumonia during COVID-19 pandemic : What We should know about ?(雲林台大 陳彥甫 醫師) | |
| 20200717 Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study | |
| 20200821 Vaccination of SARS-CoV-2 | |
| 20200918 武漢肺炎回顧 | |
| 20201016 外師：Triple Therapy for COPD（台中榮總 詹明澄 醫師) | |
| 20201016 Dexamethasone in Hospitalized - Recovery Trial | |
| 20201113 Lung and Diaphragm Protective Ventilation | |
| 20201204 外師：Role of TS-1 in Platinum Treatment failure NSCLC（東洋藥品 陳鈺潔) | |
| 20201211 Mild or moderate COVID-19 | |